ArticleDrugs & aging2020

Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD).

Serena Porcari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.